ChitoCore
Circular Biomaterials Platform
Australian-made fungal chitosan

Building a circular biomaterials platform from mushroom waste.

ChitoCore is developing an Australian fungal chitosan manufacturing platform designed to valorise mushroom industry by-products, reduce dependence on imported materials, and supply high-value biomaterials to multiple industrial sectors.

Core proposition
Waste valorisation into industrial biomaterials

A feedstock-to-material platform converting mushroom processing side streams into fungal-derived chitosan and related products with broad application potential.

Supply anchor
Marland Mushrooms

Partnership-led feedstock model centred on mushroom by-product recovery and local industrial integration.

Market logic
Multi-sector demand

Chitosan is useful across wine, agriculture, water treatment, and sustainable materials.

Investment thesis

ChitoCore sits at the intersection of circular economy, advanced manufacturing, and industrial biomaterials.

Circular feedstock model

ChitoCore is building a circular biomaterials platform that converts mushroom industry by-products into high-value fungal chitosan and related materials.

Australian supply chain

A locally anchored manufacturing model designed to reduce reliance on imported chitosan and strengthen sovereign capability in advanced biomaterials.

Platform chemistry

Fungal-derived chitosan can serve multiple industries, creating a versatile commercial pathway rather than dependence on a single end market.

Platform overview

From mushroom waste stream to premium fungal chitosan platform.

ChitoCore is designed around a simple commercial idea: recover value from mushroom-processing by-products and turn that feedstock into a versatile class of industrial biomaterials. The initial product focus is fungal-derived chitosan, with the broader platform designed to support derivatives and future material extensions over time.

01

Waste to value

ChitoCore is designed to turn mushroom industry waste streams into commercially useful outputs, converting disposal cost and inefficiency into material value.

02

Partnership-led supply

The model is built around feedstock partnerships, including engagement with Marland Mushrooms, to secure reliable input streams for scale-up and pilot deployment.

03

Manufacturing platform

Rather than a single-product story, ChitoCore is developing a broader fungal biomaterials platform centred on chitosan and adjacent high-value derivatives.

04

Cross-industry demand

Chitosan has relevance across wine, agriculture, water treatment, and advanced materials, supporting diversified market entry and long-term optionality.

Why now
Strategic momentum
Partnership pathway with Marland Mushrooms for mushroom-processing side streams
Waste valorisation model built around underutilised organic by-products
Scalable fungal chitosan manufacturing platform with multi-industry applications
Commercial positioning around premium Australian-made circular biomaterials
Applications

A material platform with multiple commercial pathways.

Chitosan is commercially attractive because it can serve more than one industry. ChitoCore’s investor story is not limited to a single niche: it is a manufacturing platform with multiple routes to market.

Wine & Beverage

Clarification, microbial control, process performance, and premium production support.

Agriculture

Biostimulants, crop-input systems, seed and foliar applications, and circular farm inputs.

Water Treatment

Flocculation, contaminant capture, and more sustainable treatment chemistry.

Advanced Materials

Films, composites, specialty formulations, and future biomaterials development.

Feedstock
Mushroom industry side streams
Output
Fungal chitosan and related biomaterials
Outcome
Circular Australian manufacturing with cross-sector relevance
Contact

For investors, strategic partners, and pilot collaborators.

ChitoCore is building a premium circular biomaterials platform around fungal-derived chitosan. For investment discussions, feedstock partnerships, commercial trials, or industrial collaboration, get in touch.